Warren Buffett is confused about retail trade stating “retailing is tough for me to figure out“. Not only is the retail model changing – but consumer spending and inflation trends are changing also. Mr. Buffett was lamenting about missing the Amazon
March 4, 2017
The good news is: • All of the major averages hit all time highs last Wednesday. The Negatives The breadth indicators weakened a little over the past week. The secondaries continue to under perform the blue chips. After hitting an
“Managers and investors alike must understand that accounting numbers are the beginning, not the end, of business valuation.” Warren Buffett Accounting is the language of business and for many people, it is the equivalent of getting a root canal. If
The global chemical industry got off to a positive start in 2017 with January seeing a rise in chemical production on gains across most regions, according to the latest monthly report from the American Chemistry Council (“ACC”). Encouraging January Readings
AUD/USD gained 70 points last week, closing just below the 0.76 level. This week’s key event are Retail Sales and the Cash Rate. Here is an outlook on the major market-movers and an updated technical analysis for AUD/USD. In the US, Donald Trump’s speech disappointed
Fundamental Forecast for Gold: Bullish For only the second time in ten weeks, gold prices finished the week lower. The biggest development of the past week driving gold lower was the Fed’s interest rate expectations. On Monday, Fed Fund futures were
In the CFTC reporting period ending on February 28, speculators mostly added to gross long foreign currency futures and reduced gross short exposure. The skepticism about the dollar came amid a dramatic shift in expectations of the timing and not
I evaluated 49 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. I also put each company through the ModernGraham valuation model based
A few weeks after Donald Trump was elected president of the United States, he was asked about pharmaceuticals prices. With typical rhetorical gusto, he declared, “Pharmaceutical companies are getting away with murder.” Well, my firm has been increasing our allocation
Mounting evidence of stretched valuations, amid droning debates about‘how high is high’ and ‘can this keep going’ discussions, have not combined to derail our primary uptrend from Election Day to this point. We have noted this every day and every week during our
